Is ALR Technologies Inc. (ALRTF) a Buy, Sell, or Hold?
ALR Technologies Inc.
OTC:ALRTF
$0.02 USD
$0 (0.0%)
- Volume
- 100K
- Average Volume
- 28.52K
- Market Capitalization
- $12.91M
- P/E Ratio
- -1.35
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $0.03
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.01
Industry, Sector & symbol
| Stock Exchange | OTC |
| CEO | Sidney S. Chan |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Current Symbol | ALRTF |
| CUSIP | None |
| CIK | 0001930419 |
| Web | https://www.alrt.com |
| Phone | 804 554 3500 |
| Currency | USD |
| Employees | 7 |
| Country | SG |
Liquidity
| Debt-to-Equity Ratio | -0.79 |
| Payout Ratio | 0.00 |
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Cash Ratio | 0.00 |
Sales & Book Value
| Annual Sales | $7468 |
| Price / Sales | 0.00 |
| Cash Flow | 0.00 |
| Price / Cash Flow | 0.00 |
| Price / Book | -0.66 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.0222 |
| Trailing P/E Ratio | -1.35 |
| PEG Ratio | 0.04 |
| P/E Growth | 0.04 |
| Net Income | $-11.9M |
| Net Margin | -159306.37% |
| Pretax Margin | -113055.70% |
| Return on Equity | 51.64% |
| Return on Assets | -6157.33% |
Financials Score
| AltmanZ Score | -5892.40 |
| Piotroski Score | 1.00 |
| Working Capital | -39.86M |
| Total Assets | 47.37K |
| Ebit | -3.05M |
| Market Cap | 12.91M |
| Total Liabilities | 39.91M |
Poll Results
About ALR Technologies Inc. (OTC:ALRTF) Stock
ALR Technologies Inc. is a data management company dedicated to creating and providing diabetes care solutions for both human and animal health sectors across the United States. Central to its offerings is the comprehensive Diabetes Management System. This system facilitates data collection, provides predictive A1C analysis, offers recommendations for insulin dosage adjustments, tracks performance, enables remote patient monitoring, and supplies essential diabetes testing materials. The company also markets Continuous Glucose Monitoring (CGM) devices, which are wearable medical technologies designed to provide continuous blood sugar readings. Addressing a specific need in veterinary medicine, ALR Technologies offers the GluCurve Pet CGM, tailored for diabetic felines and canines, and utili ... zed by veterinarians. Furthermore, their Prediabetes System supports patients with educational video content, supplementary resources optimized for mobile devices, and a private online community for discussing disease management strategies. ALR Technologies primarily serves healthcare providers, health insurance companies, and entities specializing in disease and case management services, including those within the home care industry. Originally incorporated in 1987 as Mo Betta Corp., the company rebranded to ALR Technologies Inc. in December 1998. It is based in Richmond, Virginia, and operates as a subsidiary of ALR Technologies SG Ltd.
2026-06-30 12:00:00
ALR Technologies Announces Strategic Acquisition of CGM Medical Technology for US$45 Million and 200M Shares PR Newswire
2026-06-30 11:26:00
SINGAPORE, June 30, 2026 /PRNewswire/ -- ALR Technologies SG Ltd ("ALRT" or the "Company") (OTC: ALRTF), the diabetes management company, announces it has entered into a Letter of Intent ("LOI") to acquire 100% equity of CGM Medical Technology Singapore Pte. Ltd. ("CGM Medical Singapore") and assets of CGM Medical Technology Shenzhen Ltd ("CGM Medical Shenzhen") for an aggregate purchase price of 200 million ordinary shares and US$45 million, payable upon certain conditions being met (collectively the "Transactions").
ALR TECHNOLOGIES HAS LAUNCHED THE GLUCURVE PET CGM IN CANADA
2026-05-19 08:28:00
SINGAPORE, May 19, 2026 /PRNewswire/ -- ALR Technologies SG Ltd. ("ALRT" or the "Company") (OTC: ALRTF), the diabetes management company, announces the GluCurve Pet CGM ("GluCurve") is now for sale in Canada at www.GluCurve.ca.
Frequently Asked Questions
-
What is the current ALR Technologies Inc. (ALRTF) stock price?
-
ALR Technologies Inc.(OTC:ALRTF) stock price is $0.02 in the last trading session. During the trading session, ALRTF stock reached the peak price of $0.025 while $0.0033 was the lowest point it dropped to. The percentage change in ALRTF stock occurred in the recent session was 0.0% while the dollar amount for the price change in ALRTF stock was $0.
-
ALRTF's industry and sector of operation?
-
The OTC listed ALRTF is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of ALRTF?
-
Joe Stern | Head of Animal Health
Benjamin Szeto | Chief Legal Counsel, General Counsel & Secretary
Sidney S. Chan | Chairman, Chief Executive Officer, President, Chief Financial Officer, Chief Accounting Officer & Treasurer
Steven Brassard | Director of Finance, Accounting & Administration
Christine Y. S. Kan | Vice President of Corporate Development & Director -
How many employees does ALRTF have?
-
Number of ALRTF employees currently stands at 7. ALRTF operates from 7400 Beaufont Springs Drive, Singapore, VA 23225, SG.
-
Link for ALRTF official website?
-
Official Website of ALRTF is: https://www.alrt.com
-
How do I contact ALRTF?
-
ALRTF could be contacted at phone #804 554 3500 and can also be accessed through its website. ALRTF operates from 7400 Beaufont Springs Drive, Singapore, VA 23225, SG.
-
How many shares of ALRTF are traded daily?
-
The average number of ALRTF shares traded daily for last 3 months was 28.52K.
-
What is the market cap of ALRTF currently?
-
The market value of ALRTF currently stands at $12.91M with its latest stock price at $0.02